Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The role of vitamin C in epigenetic cancer therapy

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Extracellular superoxide dismutase is present in secretory vesicles of human neutrophils and released upon stimulation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Roles of sedentary aging and lifelong physical activity in exchange of glutathione across exercising human skeletal muscle

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pregnancy outcomes in women with type 1 diabetes using insulin degludec

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Control interventions in randomised trials among people with mental health disorders

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

Formation of reactive oxygen species has been linked to the development of diabetes complications. Treatment with metformin has been associated with a lower risk of developing diabetes complications, including when used in combination with insulin. Metformin inhibits Complex 1 in isolated mitochondria and thereby decreases the formation of reactive oxygen species. Thus, we post-hoc investigated the effect of metformin in combination with different insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes. Four hundred and fifteen individuals with type 2 diabetes were randomized (1:1) to blinded treatment with metformin (1,000 mg twice daily) versus placebo and to (1:1:1) open-label biphasic insulin, basal-bolus insulin, or basal insulin therapy in a 2 × 3 factorial design. RNA and DNA oxidation were determined at baseline and after 18 months measured as urinary excretions of 8-oxo-7,8-dihydroguanosine (8-oxoGuo) and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), respectively. Urinary excretion of 8-oxoGuo changed by +7.1% (95% CI: 0.5% to 14.0%, P = 0.03) following metformin versus placebo, whereas changes in 8-oxodG were comparable between intervention groups. Biphasic insulin decreased urinary excretion of 8-oxoGuo (within-group: -9.6% (95% CI: -14.4% to -4.4%)) more than basal-bolus insulin (within-group: 5.2% (95% CI: -0.5% to 11.2%)), P = 0.0002 between groups, and basal insulin (within-group: 3.7% (95% CI: -2.0% to 9.7%)), P = 0.0007 between groups. Urinary excretion of 8-oxodG decreased more in the biphasic insulin group (within-group: -9.9% (95% CI: -14.4% to -5.2%)) than basal-bolus insulin (within group effect: -1.2% (95% CI: -6.1% to 3.9%)), P = 0.01 between groups, whereas no difference was observed compared with basal insulin. In conclusion, eighteen months of metformin treatment in addition to different insulin regimens increased RNA oxidation, but not DNA oxidation. Biphasic insulin decreased both RNA and DNA oxidation compared with other insulin regimens.

OriginalsprogEngelsk
TidsskriftFree Radical Biology & Medicine
Vol/bind178
Sider (fra-til)18-25
Antal sider8
ISSN0891-5849
DOI
StatusUdgivet - jan. 2022

Bibliografisk note

Copyright © 2021. Published by Elsevier Inc.

ID: 69352684